A biomarker in a blood test makes it possible to diagnose Alzheimer’s disease
A study by the hospital Clínic Barcelona-IDIBAPS, published in the journal Neurology, confirms the usefulness of a blood-based biomarker to diagnose1
A study by the hospital Clínic Barcelona-IDIBAPS, published in the journal Neurology, confirms the usefulness of a blood-based biomarker to diagnose1
Researchers from the CAPSBE and from IDIBAPS have shown that older adults have difficulty in making use of tele-consult services, and that the increa1
This distinction is one of the highest honours awarded by the College to members who have made outstanding contributions to the field of rheumatology1
On 18 November, the Spanish Cancer Research Association (ASEICA) presented the awards, with which it recognises the efforts of Spanish researchers in1
The list, published by Clarivate Analytics, identifies the most influential experts, who are among the 1% most highly cited in their speciality in di1
The prize was awarded at the recent congress of the Spanish Society of Thrombosis and Haemostasis (SETH), which took place in Barcelona in early-Octo1
The Japanese company, leader in screening for colorectal cancer worldwide, will fund the first phase of a multicenter clinical trial led by Antoni Ca1
On 3 November 2022, the TV3 Marató Foundation announced the research projects that will receive funding from the 2021 Marató, dedicated to mental dis1
The visit is part of a new communication project aimed at raising awareness of the research carried out at the Institute among patients and patient a1
Over the next three years, Eduard Vieta and his team will lead the Clínic-IDIBAPS contribution to this project, which has the support of the European1